Furthermore, a balanced unimolecular GLP‐1R and GIPR agonist reduced bodyweight, food intake, and fat mass in mice with diet‐induced obesity to a greater extent than liraglutide.127. This evidence concerns the gene GIPR and obesity due to melanocortin 4 receptor deficiency.